Skip to content

Effect of colchicine, an anti-inflammatory drug, on the chance of developing atrial fibrillation, a fast irregular heart beat, in open heart surgery patients

Effect of colchiciNe on the inciDence of Atrial Fibrillation in open heart surgery patients: The END-AF trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15501019
Enrollment
360
Registered
2015-12-31
Start date
2012-10-16
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation post cardiac surgery Circulatory System Atrial fibrillation post cardiac surgery

Interventions

Patients are randomized at least 12 to 24 hours prior to surgery to receive colchicine or no colchicine in an open label format. Randomization was performed by the principal investigator using an onl

Sponsors

Jordan Collaborative Cardiology Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All adult patients undergoing elective cardiac surgery and cared for by participating cardiologists.

Exclusion criteria

Exclusion criteria: 1. Patients with a documented history of AF or supraventricular arrhythmia or, with absence of sinus rhythm on hospital admission 2. Known severe liver disease or current transaminases >1.5 times the upper normal limit 3. Current serum creatinine >2.5 mg/dl 4. Known myopathy or elevated baseline preoperative creatine kinase 5. Known blood dyscrasias 6. Significant gastrointestinal disease 7. Pregnant and lactating women 8. Known hypersensitivity to colchicine 9. Current treatment with colchicine for any indications 10. Emergency surgery

Design outcomes

Primary

MeasureTime frame
1. Rate of AF is measured through continuous ECG monitoring until the time of discharge. Episodes of AF lasting for 5 minutes or more are continued significant and are recorded. 2. Occurrence of side effects is determined through daily patient examinations and patient interviews until the time of discharge

Countries

Jordan

Contacts

Public ContactRamzi Tabbalat

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026